IN8BIO INC. - COMMON

0.2400

08-十月-24 10:45:58

15 分钟延时

股票

-0.0150

-5.88%

今日范围

0.2370 - 0.2599

ISIN

N/A

来源

NASDAQ

IN8bio Completes Dosing of First Cohort in Phase 1 Clinical Trial with Allogeneic Gamma Delta T-Cell Therapy in Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant

11 8月 2021 08:00:01 条件 Nasdaq GlobeNewswire
IN8bio Appoints Emily Fairbairn and Luba Greenwood to Board of Directors

04 8月 2021 08:00:01 条件 Nasdaq GlobeNewswire
IN8bio Announces Pricing of Initial Public Offering

30 7月 2021 07:00:00 条件 Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

我同意 NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie 政策, 隐私政策 and 条款与条件.